DR LAL PATHLABS
Back to Balance Sheet
|
DR LAL PATHLABS Last 5 Year Deferred Tax Assets / Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Deferred Tax Assets / Liabilities | ₹-83 Cr | ₹-42 Cr | ₹-37 Cr | ₹-33 Cr | ₹-27 Cr |
What is the latest Deferred Tax Assets / Liabilities ratio of DR LAL PATHLABS ?
| Year | Deferred Tax Assets / Liabilities |
|---|---|
| Mar2025 | ₹-83 Cr |
| Mar2024 | ₹-42 Cr |
| Mar2023 | ₹-37 Cr |
| Mar2022 | ₹-33 Cr |
| Mar2021 | ₹-27 Cr |
How is Deferred Tax Assets / Liabilities of DR LAL PATHLABS Trending?
| Years | Deferred Tax Assets / Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹-83 Cr | Negative | |
| Mar2024 | ₹-42 Cr | Negative | |
| Mar2023 | ₹-37 Cr | Negative | |
| Mar2022 | ₹-33 Cr | Negative | |
| Mar2021 | ₹-27 Cr | - | |
Compare Deferred Tax Assets / Liabilities of peers of DR LAL PATHLABS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| DR LAL PATHLABS | ₹22,583.3 Cr | 1.6% | -3.4% | 4.2% | Stock Analytics | |
| APOLLO HOSPITALS ENTERPRISE | ₹109,010.0 Cr | 4.4% | -1.5% | 14.5% | Stock Analytics | |
| MAX HEALTHCARE INSTITUTE | ₹95,917.1 Cr | 3.4% | -9% | -14.6% | Stock Analytics | |
| FORTIS HEALTHCARE | ₹62,672.9 Cr | 1.3% | -9.7% | 29.4% | Stock Analytics | |
| NARAYANA HRUDAYALAYA | ₹34,854.8 Cr | 3.5% | -8.7% | -1.8% | Stock Analytics | |
| GLOBAL HEALTH | ₹27,185.5 Cr | -0.3% | -13.2% | -21.3% | Stock Analytics | |
DR LAL PATHLABS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| DR LAL PATHLABS | 1.6% |
-3.4% |
4.2% |
| SENSEX | -1.9% |
-9.1% |
-0.2% |
You may also like the below Video Courses